Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone vs Triamcinolone for Sacroiliac Joint Injection
NCT05134181Phase 2Unknown
- Sponsor
- Mansoura University
- Start
- Aug 2021
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of methylprednisolone and triamcinolone acetonide in Sacroiliitis (SIJ) (2 arms), sponsored by Mansoura University. Primary endpoint: Numerical Rating Scale for Pain at 3 months. Status: unknown.
02
Drugs
methylprednisolonetriamcinolone acetonide
03
Conditions
Sacroiliitis (SIJ)
Beyond the preview
Go deeper on NCT05134181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05134181.